SurModics Stock Price, News & Analysis (NASDAQ:SRDX)

$27.45 -0.10 (-0.36 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$27.45
Today's Range$27.30 - $28.17
52-Week Range$21.90 - $34.15
Volume19,025 shs
Average Volume24,341 shs
Market Capitalization$360.91 million
P/E Ratio65.60
Dividend YieldN/A
Beta0.81

About SurModics (NASDAQ:SRDX)

SurModics logoSurmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Receive SRDX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution - NEC
Sub-IndustryHealth Care Equipment
SectorMedical Equipment, Supplies & Distribution - NEC
SymbolNASDAQ:SRDX
CUSIP86887310
Phone+1-952-5007000

Debt

Debt-to-Equity RatioN/A
Current Ratio3.07%
Quick Ratio2.87%

Price-To-Earnings

Trailing P/E Ratio65.6
Forward P/E Ratio-549.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$73.11 million
Price / Sales4.96
Cash Flow$0.96 per share
Price / Cash28.68
Book Value$8.38 per share
Price / Book3.28

Profitability

Trailing EPSN/A
Net Income$3.92 million
Net Margins0.10%
Return on Equity5.04%
Return on Assets4.16%

Miscellaneous

Employees257
Outstanding Shares13,200,000

SurModics (NASDAQ:SRDX) Frequently Asked Questions

What is SurModics' stock symbol?

SurModics trades on the NASDAQ under the ticker symbol "SRDX."

How were SurModics' earnings last quarter?

SurModics, Inc. (NASDAQ:SRDX) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.15. The business had revenue of $17.01 million for the quarter, compared to analysts' expectations of $17.69 million. SurModics had a return on equity of 5.04% and a net margin of 0.10%. View SurModics' Earnings History.

Where is SurModics' stock going? Where will SurModics' stock price be in 2018?

2 equities research analysts have issued 1-year price objectives for SurModics' shares. Their predictions range from $40.00 to $40.00. On average, they expect SurModics' stock price to reach $40.00 in the next year. View Analyst Ratings for SurModics.

Who are some of SurModics' key competitors?

Who are SurModics' key executives?

SurModics' management team includes the folowing people:

  • Susan E. Knight, Independent Chairman of the Board (Age 63)
  • Gary R. Maharaj, President, Chief Executive Officer, Director (Age 54)
  • Andrew D. C. LaFrence, Chief Financial Officer , Vice President - Finance and Information Systems (Age 54)
  • Thomas A. Greaney, Chief Operating Officer - Medical Devices (Age 51)
  • Bryan K. Phillips, Senior Vice President - Legal and Human Resources, General Counsel & Secretary (Age 46)
  • Charles W. Olson, Senior Vice President - Commercial and Business Development, Medical Devices (Age 53)
  • Joseph J. Stich, Vice President, General Manager - In Vitro Diagnostics (Age 52)
  • Timothy J. Arens, Vice President - Corporate Development and Strategy (Age 50)
  • Gregg S. Sutton, Vice President - Research and Development, Medical Devices (Age 58)
  • Jose H. Bedoya, Independent Director (Age 61)

Who owns SurModics stock?

SurModics' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.45%), Renaissance Technologies LLC (7.75%), Disciplined Growth Investors Inc. MN (1.35%), Bank of New York Mellon Corp (1.18%), Segall Bryant & Hamill LLC (1.07%) and Geode Capital Management LLC (1.01%). Company insiders that own SurModics stock include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Joseph J Stich, Susan E Knight and Timothy J Arens. View Institutional Ownership Trends for SurModics.

Who sold SurModics stock? Who is selling SurModics stock?

SurModics' stock was sold by a variety of institutional investors in the last quarter, including Cornerstone Capital Management Holdings LLC., Bank of New York Mellon Corp, Geode Capital Management LLC, Two Sigma Advisers LP, Rice Hall James & Associates LLC, Metropolitan Life Insurance Co. NY, Two Sigma Investments LP and Foundry Partners LLC. Company insiders that have sold SurModics company stock in the last year include Bryan K Phillips, Charles W Olson, Gary R Maharaj and Joseph J Stich. View Insider Buying and Selling for SurModics.

Who bought SurModics stock? Who is buying SurModics stock?

SurModics' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Arizona State Retirement System, Segall Bryant & Hamill LLC, Jefferies Group LLC, Guggenheim Capital LLC, MetLife Investment Advisors LLC, Wells Fargo & Company MN and Deutsche Bank AG. View Insider Buying and Selling for SurModics.

How do I buy SurModics stock?

Shares of SurModics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SurModics' stock price today?

One share of SurModics stock can currently be purchased for approximately $27.45.

How big of a company is SurModics?

SurModics has a market capitalization of $360.91 million and generates $73.11 million in revenue each year. SurModics employs 257 workers across the globe.

How can I contact SurModics?

SurModics' mailing address is 9924 W 74th St, EDEN PRAIRIE, MN 55344-3523, United States. The company can be reached via phone at +1-952-5007000 or via email at [email protected]


MarketBeat Community Rating for SurModics (SRDX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  142 (Vote Outperform)
Underperform Votes:  133 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about SurModics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

SurModics (NASDAQ:SRDX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.672.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.00$40.00$40.00$36.50
Price Target Upside: 45.19% upside45.19% upside45.19% upside32.49% upside

SurModics (NASDAQ:SRDX) Consensus Price Target History

Price Target History for SurModics (NASDAQ:SRDX)

SurModics (NASDAQ:SRDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Lake Street CapitalInitiated CoverageBuy -> Buy$40.00MediumView Rating Details
6/27/2017AegisInitiated CoverageBuyHighView Rating Details
11/21/2016Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
10/6/2016SidotiDowngradeBuy -> Neutral$33.00N/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

SurModics (NASDAQ:SRDX) Earnings History and Estimates Chart

Earnings by Quarter for SurModics (NASDAQ:SRDX)

SurModics (NASDAQ SRDX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018Q1 2018($0.05)$0.10$17.69 million$17.01 millionViewN/AView Earnings Details
11/8/2017Q4 2017($0.01)$0.18$16.98 million$20.06 millionViewN/AView Earnings Details
8/3/2017Q3 2017($0.01)$0.09$15.98 million$17.80 millionViewListenView Earnings Details
4/27/2017Q2 2017$0.07$0.05$16.21 million$17.50 millionViewN/AView Earnings Details
2/2/2017Q117$0.09$0.19$15.81 million$17.80 millionViewListenView Earnings Details
11/16/2016Q4 2016$0.09$0.26$16.09 million$18.20 millionViewListenView Earnings Details
7/28/2016Q316$0.12$0.37$16.31 million$19.97 millionViewListenView Earnings Details
5/2/2016Q2$0.09$0.20$14.71 million$16.70 millionViewListenView Earnings Details
1/28/2016Q116$0.17$0.38$14.58 million$16.50 millionViewListenView Earnings Details
11/10/2015Q415$0.19$0.30$15.30 million$17.40 millionViewListenView Earnings Details
8/5/2015Q315$0.21$0.26$14.86 million$15.90 millionViewListenView Earnings Details
4/30/2015Q2$0.20$0.19$14.09 million$14.40 millionViewListenView Earnings Details
1/29/2015Q414$0.21$0.25$14.30 million$14.20 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.26$14.90 million$15.30 millionViewN/AView Earnings Details
7/31/2014Q214$0.23$0.27$14.84 million$14.62 millionViewListenView Earnings Details
5/1/2014Q114$0.20$0.22$14.40 million$13.60 millionViewListenView Earnings Details
1/30/2014Q413$0.21$0.21$14.15 million$13.90 millionViewListenView Earnings Details
11/5/2013Q313$0.22$0.26$14.32 million$14.30 millionViewListenView Earnings Details
7/31/2013Q3 2013$0.21$0.22$15.03 million$14.29 millionViewListenView Earnings Details
5/7/2013Q2 2013$0.21$0.20$13.92 million$13.70 millionViewListenView Earnings Details
1/30/2013Q1 2013$0.18$0.29$13.63 million$13.85 millionViewListenView Earnings Details
11/6/2012Q412$0.17$0.17$13.83 million$13.80 millionViewN/AView Earnings Details
8/1/2012$0.14$0.17ViewN/AView Earnings Details
5/8/2012$0.15$0.14ViewN/AView Earnings Details
2/6/2012Q1 2012$0.11$0.11ViewN/AView Earnings Details
11/3/2011$0.05$0.06ViewN/AView Earnings Details
8/3/2011$0.04$0.13ViewN/AView Earnings Details
4/27/2011$0.08ViewN/AView Earnings Details
1/26/2011$0.05ViewN/AView Earnings Details
11/10/2010Q4 2010$0.13($0.05)ViewN/AView Earnings Details
7/28/2010Q3 2010$0.14$0.11ViewN/AView Earnings Details
4/28/2010Q2 2010$0.16$0.10ViewN/AView Earnings Details
1/27/2010Q1 2010$0.19$0.11ViewN/AView Earnings Details
11/4/2009Q4 2009$0.20$0.16ViewN/AView Earnings Details
7/29/2009Q3 2009$0.21$0.20ViewN/AView Earnings Details
4/29/2009Q2 2009$0.21$0.24ViewN/AView Earnings Details
1/28/2009Q1 2009$0.26$0.48ViewN/AView Earnings Details
11/5/2008Q4 2008$0.28$0.20ViewN/AView Earnings Details
7/23/2008Q3 2008$0.31$0.26ViewN/AView Earnings Details
4/23/2008Q2 2008$0.30$0.28ViewN/AView Earnings Details
1/23/2008Q1 2008$0.32$0.31ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

SurModics (NASDAQ:SRDX) Earnings Estimates

2018 EPS Consensus Estimate: $0.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.01$0.01$0.01
Q2 20181$0.06$0.06$0.06
Q3 20181$0.06$0.06$0.06
Q4 20181$0.07$0.07$0.07
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for SurModics (NASDAQ:SRDX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

SurModics (NASDAQ SRDX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.70%
Institutional Ownership Percentage: 84.76%
Insider Trades by Quarter for SurModics (NASDAQ:SRDX)
Insider Trades by Quarter for SurModics (NASDAQ:SRDX)

SurModics (NASDAQ SRDX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/11/2017Joseph J StichVPSell1,000$30.18$30,180.0046,450View SEC Filing  
9/15/2017Charles W OlsonVPSell801$27.85$22,307.8526,585View SEC Filing  
9/11/2017Joseph J. StichVPSell1,000$27.28$27,280.00View SEC Filing  
8/7/2017Gary R MaharajCEOSell5,000$25.75$128,750.00126,807View SEC Filing  
7/3/2017Gary R MaharajCEOSell5,000$28.03$140,150.00131,807View SEC Filing  
6/16/2017Bryan K PhillipsSVPSell1,226$24.85$30,466.1029,208View SEC Filing  
6/9/2017Joseph J StichVPSell1,000$25.31$25,310.0040,672View SEC Filing  
6/5/2017Gary R MaharajCEOSell2,702$25.09$67,793.18136,807View SEC Filing  
4/3/2017Gary R. MaharajCEOSell584$25.00$14,600.00View SEC Filing  
3/6/2017Joseph J. StichVPSell1,000$24.73$24,730.00View SEC Filing  
12/22/2016Charles W OlsonVPSell1,201$26.00$31,226.0027,386View SEC Filing  
12/8/2016Charles W OlsonVPSell3,699$26.02$96,247.9828,587View SEC Filing  
12/5/2016Joseph J StichVPSell1,000$23.97$23,970.0042,362View SEC Filing  
12/2/2016Bryan K PhillipsSVPSell1,264$23.90$30,209.6029,170View SEC Filing  
11/25/2016Charles W OlsonVPSell500$26.02$13,010.0027,245View SEC Filing  
11/7/2016Gary R MaharajCEOSell5,000$25.22$126,100.00130,207View SEC Filing  
10/3/2016Gary R. MaharajCEOSell5,000$29.55$147,750.00View SEC Filing  
8/17/2016Charles W OlsonVPSell9,936$28.98$287,945.2833,098View SEC Filing  
8/15/2016Susan E. KnightDirectorSell1,548$28.64$44,334.72View SEC Filing  
8/1/2016Charles W OlsonVPSell12,500$27.08$338,500.0035,531View SEC Filing  
6/14/2016Bryan K PhillipsSVPSell1,816$23.44$42,567.0425,350View SEC Filing  
6/10/2016Joseph J StichVPSell1,000$23.33$23,330.0023,492View SEC Filing  
5/27/2016Susan E KnightDirectorSell1,001$22.71$22,732.7116,470View SEC Filing  
3/4/2016Timothy J ArensVPSell10,291$18.43$189,663.139,196View SEC Filing  
12/4/2015Joseph J StichVPSell1,000$21.18$21,180.0021,464View SEC Filing  
9/4/2015Joseph J StichVPSell1,000$23.57$23,570.0022,464View SEC Filing  
6/5/2015Joseph J StichVPSell1,000$23.84$23,840.00View SEC Filing  
5/22/2015Bryan K PhillipsSVPSell7,293$25.25$184,148.25View SEC Filing  
12/29/2014Charles W OlsonVPSell5,083$21.98$111,724.34View SEC Filing  
12/8/2014Charles W OlsonVPSell3,365$21.66$72,885.90View SEC Filing  
11/19/2014Timothy J ArensVPSell10,330$21.02$217,136.60View SEC Filing  
5/8/2014Susan KnightDirectorBuy1,500$20.36$30,540.004,800View SEC Filing  
12/4/2013Bryan PhillipsSVPSell16,236$22.95$372,616.2016,233View SEC Filing  
5/15/2013Mark A LehmanInsiderSell1,693$26.55$44,949.15View SEC Filing  
8/10/2012Value Lp StarboardMajor ShareholderSell257,560$17.74$4,569,114.40View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

SurModics (NASDAQ SRDX) News Headlines

Source:
DateHeadline
Surmodics to Host Virtual Annual Meeting of ShareholdersSurmodics to Host Virtual Annual Meeting of Shareholders
finance.yahoo.com - February 13 at 8:45 AM
SurModics (SRDX) Upgraded at Zacks Investment ResearchSurModics (SRDX) Upgraded at Zacks Investment Research
www.americanbankingnews.com - February 9 at 8:58 PM
SurModics (SRDX) Releases Quarterly  Earnings Results, Beats Estimates By $0.15 EPSSurModics (SRDX) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS
www.americanbankingnews.com - February 9 at 6:26 PM
Surmodics (SRDX) Beats on Earnings in Q1, Guidance SolidSurmodics (SRDX) Beats on Earnings in Q1, Guidance Solid
www.zacks.com - February 9 at 8:49 AM
SurModics reports 1Q lossSurModics reports 1Q loss
finance.yahoo.com - February 8 at 9:18 AM
Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 GuidanceSurmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
finance.yahoo.com - February 8 at 9:18 AM
Head to Head Survey: LDR (LDRH) vs. SurModics (SRDX)Head to Head Survey: LDR (LDRH) vs. SurModics (SRDX)
www.americanbankingnews.com - February 1 at 5:12 AM
Surmodics to Webcast First Quarter Fiscal 2018 Earnings Conference Call on February 8Surmodics to Webcast First Quarter Fiscal 2018 Earnings Conference Call on February 8
finance.yahoo.com - January 30 at 9:03 AM
BRIEF-Surmodics Receives FDA Clearance For Telemark Peripheral Support MicrocatheterBRIEF-Surmodics Receives FDA Clearance For Telemark Peripheral Support Microcatheter
www.reuters.com - January 22 at 5:22 PM
Surmodics Receives 510(K) Clearance for Telemark™ Coronary/Peripheral Support Microcatheter from the U.S. Food and Drug AdministrationSurmodics Receives 510(K) Clearance for Telemark™ Coronary/Peripheral Support Microcatheter from the U.S. Food and Drug Administration
finance.yahoo.com - January 22 at 5:22 PM
SurModics (SRDX) Rating Increased to Sell at BidaskClubSurModics (SRDX) Rating Increased to Sell at BidaskClub
www.americanbankingnews.com - January 14 at 9:38 PM
Financial Survey: Cytori Therapeutics (CYTX) & SurModics (SRDX)Financial Survey: Cytori Therapeutics (CYTX) & SurModics (SRDX)
www.americanbankingnews.com - January 13 at 5:06 PM
Surmodics (SRDX) Poised on Core Business Amid Forex WoesSurmodics (SRDX) Poised on Core Business Amid Forex Woes
finance.yahoo.com - January 11 at 11:36 AM
New Strong Sell Stocks for January 8thNew Strong Sell Stocks for January 8th
finance.yahoo.com - January 8 at 9:05 AM
K2M Group (KTWO) and SurModics (SRDX) Head to Head SurveyK2M Group (KTWO) and SurModics (SRDX) Head to Head Survey
www.americanbankingnews.com - January 6 at 3:36 PM
SurModics (SRDX) Rating Lowered to Strong Sell at BidaskClubSurModics (SRDX) Rating Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - December 29 at 6:32 AM
Critical Analysis: SurModics (SRDX) vs. DENTSPLY SIRONA (XRAY)Critical Analysis: SurModics (SRDX) vs. DENTSPLY SIRONA (XRAY)
www.americanbankingnews.com - December 27 at 1:16 PM
SurModics, Inc. (SRDX) VP Joseph J. Stich Sells 1,000 SharesSurModics, Inc. (SRDX) VP Joseph J. Stich Sells 1,000 Shares
www.americanbankingnews.com - December 19 at 9:48 PM
Head to Head Comparison: SurModics (SRDX) & Its RivalsHead to Head Comparison: SurModics (SRDX) & Its Rivals
www.americanbankingnews.com - December 19 at 7:10 PM
Critical Comparison: T2 Biosystems (TTOO) vs. SurModics (SRDX)Critical Comparison: T2 Biosystems (TTOO) vs. SurModics (SRDX)
www.americanbankingnews.com - December 17 at 9:30 PM
Reviewing Surmodics (SRDX) and Its RivalsReviewing Surmodics (SRDX) and Its Rivals
www.americanbankingnews.com - December 12 at 7:34 PM
Surmodics (SRDX) Rating Lowered to Sell at BidaskClubSurmodics (SRDX) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - December 12 at 5:58 PM
Head to Head Survey: Surmodics (SRDX) & Its CompetitorsHead to Head Survey: Surmodics (SRDX) & Its Competitors
www.americanbankingnews.com - December 10 at 9:30 AM
SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : December 8, 2017SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : December 8, 2017
finance.yahoo.com - December 8 at 11:17 AM
Contrasting Surmodics (SRDX) and Its PeersContrasting Surmodics (SRDX) and Its Peers
www.americanbankingnews.com - December 7 at 7:24 AM
SurModics, Inc. :SRDX-US: Earnings Analysis: 2017 By the Numbers : December 5, 2017SurModics, Inc. :SRDX-US: Earnings Analysis: 2017 By the Numbers : December 5, 2017
finance.yahoo.com - December 5 at 12:48 PM
Surmodics Inc (SRDX) Files 10-K for the Fiscal Year Ended on September 30, 2017Surmodics Inc (SRDX) Files 10-K for the Fiscal Year Ended on September 30, 2017
finance.yahoo.com - December 2 at 8:17 AM
Contrasting Surmodics (SRDX) & The CompetitionContrasting Surmodics (SRDX) & The Competition
www.americanbankingnews.com - November 20 at 1:40 PM
SurModics, Inc. – Value Analysis (NASDAQ:SRDX) : November 14, 2017SurModics, Inc. – Value Analysis (NASDAQ:SRDX) : November 14, 2017
finance.yahoo.com - November 15 at 10:56 AM
Surmodics, Inc. (SRDX) Stock Rating Lowered by Zacks Investment ResearchSurmodics, Inc. (SRDX) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 15 at 9:50 AM
Surmodics Inc (SRDX): What Can We Expect In The Future?Surmodics Inc (SRDX): What Can We Expect In The Future?
finance.yahoo.com - November 14 at 8:13 AM
Surmodics, Inc. (SRDX) Receives Consensus Rating of "Hold" from BrokeragesSurmodics, Inc. (SRDX) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 14 at 1:50 AM
Head-To-Head Analysis: Antares Pharma (ATRS) and Surmodics (SRDX)Head-To-Head Analysis: Antares Pharma (ATRS) and Surmodics (SRDX)
www.americanbankingnews.com - November 13 at 1:48 AM
Surmodics, Inc. (SRDX) Releases  Earnings Results, Beats Estimates By $0.19 EPSSurmodics, Inc. (SRDX) Releases Earnings Results, Beats Estimates By $0.19 EPS
www.americanbankingnews.com - November 10 at 4:39 PM
Edited Transcript of SRDX earnings conference call or presentation 8-Nov-17 1:30pm GMTEdited Transcript of SRDX earnings conference call or presentation 8-Nov-17 1:30pm GMT
finance.yahoo.com - November 9 at 7:02 PM
Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 GuidanceSurmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
www.businesswire.com - November 9 at 1:56 PM
Surmodics, Inc. (SRDX) to Release Earnings on TuesdaySurmodics, Inc. (SRDX) to Release Earnings on Tuesday
www.americanbankingnews.com - November 7 at 3:04 AM
SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : November 2, 2017SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : November 2, 2017
finance.yahoo.com - November 2 at 9:11 AM
Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8
finance.yahoo.com - October 28 at 7:08 AM
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics ForumSurmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum
finance.yahoo.com - October 28 at 7:08 AM
Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil® Drug-Coated BalloonSurmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil® Drug-Coated Balloon
finance.yahoo.com - October 24 at 10:28 AM
ETFs with exposure to SurModics, Inc. : October 23, 2017ETFs with exposure to SurModics, Inc. : October 23, 2017
finance.yahoo.com - October 24 at 10:28 AM
Surmodics, Inc. (SRDX) Receives Average Rating of "Hold" from AnalystsSurmodics, Inc. (SRDX) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 20 at 2:48 AM
SurModics, Inc. :SRDX-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017SurModics, Inc. :SRDX-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 6 at 12:24 PM
ETFs with exposure to SurModics, Inc. : October 6, 2017ETFs with exposure to SurModics, Inc. : October 6, 2017
finance.yahoo.com - October 6 at 12:24 PM
Surmodics, Inc. (SRDX) Given Average Recommendation of "Hold" by BrokeragesSurmodics, Inc. (SRDX) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 25 at 2:38 AM
Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation CatheterSurmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter
finance.yahoo.com - September 20 at 9:22 AM
Surmodics, Inc. (SRDX) VP Charles W. Olson Sells 801 SharesSurmodics, Inc. (SRDX) VP Charles W. Olson Sells 801 Shares
www.americanbankingnews.com - September 19 at 8:32 PM
Surmodics Announces Global Approvals Of .014" Low-Profile PTA Balloon Dilation CatheterSurmodics Announces Global Approvals Of .014" Low-Profile PTA Balloon Dilation Catheter
www.thestreet.com - September 19 at 8:01 AM
Surmodics Presents Encouraging SurVeil DCB Data at VIVA MeetSurmodics Presents Encouraging SurVeil DCB Data at VIVA Meet
www.zacks.com - September 15 at 9:16 AM

SEC Filings

SurModics (NASDAQ:SRDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

SurModics (NASDAQ:SRDX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

SurModics (NASDAQ SRDX) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.